Surrey Heartlands

Joint Formulary & PAD

Umeclidinium (Incruse Ellipta) - Chronic Obstructive Pulmonary Disease (COPD)

You are here : Home > Formulary Search > Umeclidinium (Incruse Ellipta) - Chronic Obstructive Pulmonary Disease (COPD)

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Green
Formulations :
  • Inhaler (dry powder)
Formulary Status :
Primary Care
ASPH
RSFT
SASH
SABP
Associated Icons :
Guidelines BNF SPC
Restrictions / Comments :

Documentation

Guidelines (Local)
In-Check device for improving inhaler technique - Nov 16
Guidelines (Local)
COPD Primary Care Medicines Management Guidelines - updated Jun 23
Evidence Review
Incruse Ellipta for COPD - Evidence Review - May 2015
Webpage
How to use an Ellipta inhaler - video
Patient resource
How to use an Ellipta inhaler - Patient information leaflet

PAD Profile

ChemicalSubstance :
Umeclidinium (Incruse Ellipta)
Indication :
Chronic Obstructive Pulmonary Disease (COPD)
Group Name :
LAMA
Keywords :
LAMAs, antimuscarinic bronchodilators, respiratory, long-acting muscarinic antagonist
Brand Names Include :
Incruse Ellipta
Important Information :

Combination with LABA recommended in COPD.

Prescribe by BRAND.

Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Chronic Obstructive Pulmonary Disease (COPD)
Supporting Documents :
5

Other Indications

Below are listed other indications that Umeclidinium (Incruse Ellipta) is used to treat.

  • No records returned.

Other Drugs

Below are listed other drugs that are used to treat Chronic Obstructive Pulmonary Disease (COPD).

Committee Recommendations (1)

04 Mar 20 - Surrey & North West Sussex Area Prescribing Committee (formerly Prescribing Clinical Network)

The locally preferred LAMA devices are as follows:

  • Spiriva Respimat (tiotropium soft mist inhaler). Re-usable device.
  • Incruse Ellipta (Umeclidinium DPI)
  • Seebri Breezhaler (Glycopyrronium DPI)
  • Eklira Genuair (Aclidinium DPI)

Devices should be prescribed by BRAND

See full COPD guidelines for more information